Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants ...
High-frequency trading (HFT) firm Flow Traders has been handed formal regulatory approval in Japan to operate a high-speed trading business. The Financial Services Agency of Japan (FSA) registered the ...
WASHINGTON – The US Food and Drug Administration approved Flow Neuroscience’s headset that uses electrical currents to treat depression at home, the first device of its kind cleared for sale in the ...
The treatment involves wearing a headset for various at-home sessions. Flow Neuroscience via Facebook Late last year, the U.S. Food and Drug Administration (FDA) approved an at-home brain stimulation ...
The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that can cause side ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results